对阿斯提尔,异阿斯提尔和新阿斯提尔与CYP3A4相互作用机制的比较研究
Yanzhou Tao1, Yangyang Fan1, Meizi Wang1
1The College of Chemistry, Changchun Normal University, Changchun, China.
概括
这项研究研究了阿斯蒂尔,异阿斯蒂尔和新阿斯蒂尔如何与人类CYP3A4.4相互作用. 阿斯蒂尔显示出最强的结合亲和力,所有三种黄都通过键和范德瓦尔斯力相互作用.
科学领域:
- 生物化学 生化学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 细胞染色体P450 3A4 (CYP3A4) 是药物代谢中的一个关键酶.
- 黄酸是具有潜在治疗作用的植物化合物.
- 了解黄胺-CYP3A4相互作用对于药物开发和草药安全至关重要.
研究的目的:
- 阐明人体CYP3A4与三种同位素黄酸之间的相互作用机制:阿斯蒂尔,Isoastilbin和Neoastilbin.
- 为了确定这些黄素与CYP3A4.4的结合亲和力和结合方式.
- 分析CYP3A4在与黄类化合物结合时发生的结构变化.
主要方法:
- 谱分析 (光,紫外线/紫外线) 用于研究结合.
- 分子对接模拟用于预测结合点和相互作用.
- 分子动力学模拟以评估复杂的稳定性.
- 对CYP3A4二级结构变化的分析.
主要成果:
- 这三种黄都与CYP3A4表现出中度至强度的结合亲和力 (10^410^5 L·mol−1) ,其中阿斯蒂尔宾表现出最高亲和力.
- 结合导致CYP3A4内在光的静态灭以及其二次结构的改变.
- 通过键和范德瓦尔斯力与CYP3A4结合的黄类化合物,关键氨基酸在结合部位被确定.
- 分子动力学模拟证实了CYP3A4-类化合物的稳定性.
结论:
- 阿斯提尔,异阿斯提尔和新阿斯提尔通过特定的结合机制与人类CYP3A4相互作用.
- 这些黄类药物可以调节CYP3A4的活性,可能会影响药物代谢.
- 这些发现提供了关于食用这些黄类药物的药理学影响的见解.
相关概念视频
01:24Antiasthma Drugs: Methylxanthines
274
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
274
01:23Factors Affecting Protein-Drug Binding: Drug Interactions
202
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
202
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
231
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
231
01:19Factors Affecting Drug Biotransformation: Biological
180
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
180
01:19Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
01:19Antiasthma Drugs: Leukotriene Modifiers
369
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
369